CLINICAL_TRIALS
other
· 2015-09-02
Clinical Trial Update: A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors [Phase 1]
Summary
A Phase 1 dose-escalation trial of RO4987655 in patients with advanced solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED